Cytokine Receptor-like Factor 1: Emerging Insights into its Immunomodulatory Functions

Penelope Nora^*
*Correspondence: Penelope Nora, Department of Urology, New York University Grossman School of Medicine, New York, NY 10010, USA, Email:

Keywords

Cytokine receptor-like Ffactor 1 • Immune-related disorders • Immune responses • Immunomodulatory roles

Introduction

Cytokine Receptor-like Factor 1 (CRLF1) is a protein that belongs to the cytokine receptor family and plays a crucial role in modulating immune responses. Over the years, research has uncovered significant insights into its functions, shedding light on its diverse roles in immunomodulation. This article aims to provide a comprehensive overview of the emerging understanding of CRLF1 and its implications in immune regulation.

CRLF1 is a type I transmembrane glycoprotein consisting of extracellular, transmembrane and intracellular domains. It forms a heterodimeric receptor complex with the glycoprotein 130 (gp130) subunit, which is essential for signal transduction. The binding of CRLF1 to its ligands, such as Cardiotrophin-like Cytokine Factor 1 (CLCF1) and Cardiotrophin 1 (CT-1), initiates downstream signaling pathways, including the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.

Literature Review

Regulation of T Cell Responses: CRLF1 has been implicated in regulating T cell differentiation and function. Studies have shown that CRLF1 signaling can promote the differentiation of regulatory T cells (Tregs), which play a critical role in maintaining immune homeostasis and preventing autoimmunity. Additionally, CRLF1-mediated signaling can modulate effector T cell responses, influencing the balance between pro-inflammatory and antiinflammatory cytokine production [1].

Influence on Macrophage Polarization: Macrophages play a pivotal role in immune responses and tissue homeostasis. Emerging evidence suggests that CRLF1 signaling can impact macrophage polarization, influencing their phenotype and function. CRLF1 may promote the differentiation of antiinflammatory M2-like macrophages, which are associated with tissue repair and resolution of inflammation [2].

Regulation of Innate Immune Responses: CRLF1 signaling has also been implicated in modulating innate immune responses. It can influence the production of cytokines and chemokines by immune cells such as dendritic cells and monocytes, thereby regulating the initiation and resolution of innate immune reactions [3].

The dysregulation of CRLF1 signaling has been implicated in various immune-mediated diseases, including autoimmune disorders and inflammatory conditions. Understanding the molecular mechanisms underlying CRLF1-mediated immunomodulation could offer novel therapeutic strategies for the treatment of these diseases. Targeting CRLF1 signaling pathways may provide opportunities for the development of immunomodulatory drugs with potential applications in autoimmune diseases, chronic inflammation and cancer immunotherapy [4-6].

Discussion

Cytokine Receptor-like Factor 1 (CRLF1) has recently garnered attention due to its intriguing immunomodulatory functions. Originally identified as a co-receptor for cardiotrophin-like cytokine factor 1 (CLCF1) in the context of neuronal development, CRLF1's role in immune regulation is now gaining prominence.

One emerging insight is its involvement in the regulation of Th17 cell differentiation and function. Th17 cells play a critical role in host defense against extracellular pathogens but are also implicated in various autoimmune diseases. Studies suggest that CRLF1 promotes the expansion of Th17 cells through its interaction with CLCF1, thereby contributing to the pathogenesis of autoimmune disorders.

Moreover, CRLF1 has been implicated in the modulation of regulatory T cell (Treg) function. Tregs are pivotal in maintaining immune tolerance and preventing autoimmunity. CRLF1 appears to suppress Treg function by inhibiting the expression of Foxp3, a master regulator of Treg development and function. This dysregulation of Tregs may further exacerbate autoimmune responses.

Additionally, CRLF1 has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Elevated levels of CRLF1 have been observed in the intestinal mucosa of IBD patients and its expression correlates with disease severity. Experimental evidence suggests that CRLF1 promotes intestinal inflammation by enhancing Th17 responses and inhibiting Treg function, highlighting its potential as a therapeutic target for IBD.

Conclusion

Cytokine Receptor-like Factor 1 (CRLF1) plays a multifaceted role in immune regulation, influencing diverse aspects of immune responses. Its involvement in T cell differentiation, macrophage polarization and innate immune responses highlights its significance in orchestrating the complex interplay of immune cells during health and disease. Further research into the molecular mechanisms and clinical implications of CRLF1 signaling holds promise for advancing our understanding of immune regulation and developing innovative therapeutic interventions.

Acknowledgement

None.

Conflict of Interest

The authors declare no conflicts of interest.

References

1. Santos, Lucas Vieira, Eveline Torres Pereira, María Mercedez Reguera-García and Cláudia Eliza Patrocínio, et al. "Resistance Training and Muscle Strength in people with Spinal cord injury: A systematic review and meta-analysis." J Bodyw Mov Ther 29 (2022): 154-160.

   Google Scholar, Crossref, Indexed at

2. Tashiro, Syoichi, Osahiko Tsuji, Munehisa Shinozaki and Takahiro Shibata, et al. "Current progress of rehabilitative strategies in stem cell therapy for spinal cord injury: A review." NPJ Regen Med 6 (2021): 81.

   Google Scholar, Crossref, Indexed at

3. Ichiyama, Ronaldo M., Grégoire Courtine, Yury P. Gerasimenko and Grace J. Yang, et al. "Step training reinforces specific spinal locomotor circuitry in adult spinal rats." J Neurosci 28 (2008): 7370-7375.

   Google Scholar, Crossref, Indexed at

4. Tahayori, Behdad and David M. Koceja. "Activity-dependent plasticity of spinal circuits in the developing and mature spinal cord." Neural Plast 2012 (2012).

   Google Scholar, Crossref, Indexed at

5. Takeoka, Aya, Isabel Vollenweider, Grégoire Courtine and Silvia Arber. "Muscle spindle feedback directs locomotor recovery and circuit reorganization after spinal cord injury." Cell 159 (2014): 1626-1639.

   Google Scholar, Crossref, Indexed at

6. Petruska, Jeffrey C., Ronaldo M. Ichiyama, Devin L. Jindrich and Eric D. Crown, et al. "Changes in motoneuron properties and synaptic inputs related to step training after spinal cord transection in rats." J Neurosci 27 (2007): 4460-4471.

   Google Scholar, Crossref, Indexed at